DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Jassem J, Pienkowski T, Pluzanska A. et al.
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial.
J Clin Oncol 2001; 19: 1707-1715
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.